Stroke remains a leading cause of death worldwide and the first cause of disability in the western world. Ischemic stroke (IS) accounts for almost 80% of the total cases of strokes and is a complex and multifactorial disease caused by the combination of vascular risk factors, environment and genetic factors. Investigations of the genetics of atherosclerosis and IS has greatly enhanced our knowledge of this complex multifactorial disease. In this article we sought to review common single-gene disorders relevant to IS, summarize candidate gene and genome-wide studies aimed at discovering genetic stroke risk factors and subclinical phenotypes, and to briefly discuss pharmacogenetics related to stroke treatments. Genetics of IS is, in fact, one of the most promising research frontiers and genetic testing may be helpful for novel drug discoveries as well as for appropriate drug and dose selection for treatment of patients with cerebrovascular disease.

Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments / Della Morte, D; Guadagni, F; Palmirotta, R; Testa, G; Caso, V; Paciaroni, M; Abete, Pasquale; Rengo, Franco; Ferroni, P; Sacco, Rl; Rundek, T.. - In: PHARMACOGENOMICS. - ISSN 1462-2416. - 13:(2012), pp. 595-613. [10.2217/pgs.12.14]

Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments.

ABETE, PASQUALE;RENGO, FRANCO;
2012

Abstract

Stroke remains a leading cause of death worldwide and the first cause of disability in the western world. Ischemic stroke (IS) accounts for almost 80% of the total cases of strokes and is a complex and multifactorial disease caused by the combination of vascular risk factors, environment and genetic factors. Investigations of the genetics of atherosclerosis and IS has greatly enhanced our knowledge of this complex multifactorial disease. In this article we sought to review common single-gene disorders relevant to IS, summarize candidate gene and genome-wide studies aimed at discovering genetic stroke risk factors and subclinical phenotypes, and to briefly discuss pharmacogenetics related to stroke treatments. Genetics of IS is, in fact, one of the most promising research frontiers and genetic testing may be helpful for novel drug discoveries as well as for appropriate drug and dose selection for treatment of patients with cerebrovascular disease.
2012
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments / Della Morte, D; Guadagni, F; Palmirotta, R; Testa, G; Caso, V; Paciaroni, M; Abete, Pasquale; Rengo, Franco; Ferroni, P; Sacco, Rl; Rundek, T.. - In: PHARMACOGENOMICS. - ISSN 1462-2416. - 13:(2012), pp. 595-613. [10.2217/pgs.12.14]
File in questo prodotto:
File Dimensione Formato  
2012 a, Pharmacogenomics.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Accesso privato/ristretto
Dimensione 980.79 kB
Formato Adobe PDF
980.79 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/473477
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 129
  • ???jsp.display-item.citation.isi??? 115
social impact